Does type 2 cytokine signaling promote eosinophil recruitment, mucus production, and tissue swelling in chronic rhinosinusitis?

Chronic rhinosinusitis with nasal polyps (CRSwNP) is the CRS phenotype most clearly characterized by type 2 inflammation. In this setting, IL-4, IL-5, and IL-13 link epithelial dysfunction, eosinophilic infiltration, mucus hypersecretion, and remodeling that contributes to polyp enlargement.

Clinical and pathobiologic evidence

• Type 2 CRSwNP is eosinophil-rich. EPOS identifies IL-4/IL-5/IL-13 activity and eosinophil recruitment/activation as defining features, with tissue and blood eosinophil thresholds used as supportive biomarkers.
• IL-4 and IL-13 stimulate epithelial and stromal production of eotaxins (CCL11, CCL24, and CCL26). These chemokines recruit CCR3-expressing eosinophils, while IL-5 further promotes eosinophil migration, activation, and survival.
• IL-13 signaling through IL-4Rα/IL-13Rα1 and STAT6 promotes goblet-cell metaplasia/hyperplasia and increases MUC5AC expression. Together with IL-4/IL-13-associated secretory activity, this supports increased, often viscous, mucus production.

Mechanisms of swelling and impaired clearance

• IL-13 reduces epithelial-barrier proteins including desmoglein-1 and filaggrin, increasing permeability. Barrier leak and fibrin-rich tissue can promote edema and polyp growth.
• IL-4/IL-13-associated periostin induction drives extracellular-matrix remodeling, fibrosis, and tissue edema. IL-13 also reduces ciliated-cell differentiation and ciliary beat frequency, compounding mucus retention and impaired mucociliary clearance.
• The swelling link is biologically coherent and supported by remodeling and edema-associated tissue findings, although direct quantitative human evidence relating cytokine activity specifically to measured edema is less robust than for eosinophilia or mucus.

Bottom line

• The claim is well supported, particularly for type 2-high eosinophilic CRSwNP: type 2 cytokines strongly promote eosinophil recruitment and mucus overproduction and likely drive tissue swelling through epithelial-barrier disruption, fibrin deposition, and extracellular-matrix remodeling.